EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal

Kamis, 18 Juni 2020 | 17:47 WIB
EU in Advanced Talks With Johnson & Johnson on Covid-19 Vaccine Deal
[ILUSTRASI. Small bottles labeled with a 'Vaccine COVID-19' sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration]
Reporter: Sumber: Reuters | Editor: Narita Indrastiti

KONTAN.CO.ID - BRUSSELS (Reuters). The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters.

The move would be the first arranged by the European Union executive since it was mandated last week by the 27 EU national governments to use an emergency fund with more than 2 billion euros ($2.3 billion) available to reach advance purchase or call-option deals with up to six vaccine makers.

The Commission’s deal with the U.S. firm Johnson & Johnson is “in the pipeline”, a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.

A second EU source said the Commission had a call with Johnson & Johnson on Tuesday over the possible agreement on its potential vaccine.

A Commission spokesman had no comment. Johnson & Johnson was not immediately available for comment outside U.S. business hours.

It was unclear whether any deal would involve an advance purchase of the vaccine in testing, or an option to buy it.

Johnson & Johnson plans next month to start human clinical trials for its experimental vaccine against the highly contagious coronavirus, which has infected more than 8.36 million people worldwide, with 447,985 deaths.

Germany, France, Italy and the Netherlands said last week they had acquired 400 million potential vaccine doses, in principle available to all member states, from British drugmaker AstraZeneca, which is developing a COVID-19 shot in conjunction with Oxford University.

AstraZeneca signed a similar deal in May with the United States.

The health official from an EU state said the EU deal with Johnson & Johnson could be announced as early as next week, but cautioned that it might take a little longer to finalise, and there were still chances it might not be struck at all.

EU decision-making procedures pose a sticking point for the potential deal, with member states still in talks over the establishment of a steering board for vaccine negotiations with drugmakers, officials told Reuters.

They said that under a draft plan devised by the EU Commission, which is still to be approved by EU governments, a green light from just four member states would be enough to start formal EU talks with a drugmaker.

But, underlining the urgency of securing a vaccine for the EU’s 450 million population, the Commission had already begun talks with Johnson & Johnson even before the steering board has been agreed.

By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.

But the risk is justified by the need to secure enough doses for the EU population in the global race for an effective vaccine, EU officials say.

Bagikan

Berita Terbaru

Masuk ke LQ45 dan Rumor IPO Anak Usaha Bawa Saham EMTK Menguat
| Jumat, 31 Oktober 2025 | 16:51 WIB

Masuk ke LQ45 dan Rumor IPO Anak Usaha Bawa Saham EMTK Menguat

Ke depannya performa saham EMTK akan sangat bergantung ke arah bisnisnya, terutama di sektor media dan digital.

Bakal Akusisi Mah Sing, Begini Rekomendasi Saham Dharma Polimetal (DRMA)
| Jumat, 31 Oktober 2025 | 15:55 WIB

Bakal Akusisi Mah Sing, Begini Rekomendasi Saham Dharma Polimetal (DRMA)

DRMA terus mempercepat ekspansinya di sektor kendaraan listrik (EV) melalui platform Dharma Connect.

Banyak yang Janggal di Saham DADA, Berikut ini Catatannya
| Jumat, 31 Oktober 2025 | 11:00 WIB

Banyak yang Janggal di Saham DADA, Berikut ini Catatannya

Sesuatu yang janggal mulai terendus saat PT Karya Permata Inovasi Indonesia, entitas pengendali, sibuk menjual saham DADA menuju puncak.

Petani Tembakau Terbelit Masalah Kronis
| Jumat, 31 Oktober 2025 | 07:25 WIB

Petani Tembakau Terbelit Masalah Kronis

Pada musim panen tahun ini, kompetisi pembelian dari industri semakin berkurang, akibatnya harga pun cenderung turun.

Prospek Emiten Barang Konsumen FMCG Masih Menarik
| Jumat, 31 Oktober 2025 | 06:34 WIB

Prospek Emiten Barang Konsumen FMCG Masih Menarik

Kkinerja keuangan emiten konsumer cukup baik karena penurunan input cost seiring dengan melandainya harga sejumlah bahan baku

Rupiah Terkena Imbas Pemangkasan Bunga The Fed
| Jumat, 31 Oktober 2025 | 06:30 WIB

Rupiah Terkena Imbas Pemangkasan Bunga The Fed

Nilai tukar rupiah melemah terhadap dolar AS usai The Federal Rerserve (The Fed) pangkas suku bunga.

Window Dressing Datang Malu-Malu di Tahun Ini
| Jumat, 31 Oktober 2025 | 06:27 WIB

Window Dressing Datang Malu-Malu di Tahun Ini

 Meskipun ada peluang, nampaknya para fund manager tak akan agresif melakukan window dressing di tahun ini.

Geliat Ekonomi dari Legalnya Sumur Minyak Rakyat
| Jumat, 31 Oktober 2025 | 06:23 WIB

Geliat Ekonomi dari Legalnya Sumur Minyak Rakyat

Legalisasi berpotensi menciptakan efek berantai bagi ekonomi lokal, mulai dari jasa pengeboran, transportasi hingga tumbuhnya UMKM

Lahan 1 Juta Hektare Menyokong Kebijakan Bioetanol
| Jumat, 31 Oktober 2025 | 06:19 WIB

Lahan 1 Juta Hektare Menyokong Kebijakan Bioetanol

ATR/BPN erus berupaya mencari dan memetakan lahan potensial lainnya untuk menambah ketersediaan hingga 1 juta ha.

Biaya Haji Menurun, Layanan Harus Terjaga
| Jumat, 31 Oktober 2025 | 06:16 WIB

Biaya Haji Menurun, Layanan Harus Terjaga

BPKH menegaskan kesiapannya menyalurkan porsi nilai manfaat (subsidi) untuk melengkapi biaya yang dibayarkan langsung oleh jemaah (Bipih).

INDEKS BERITA

Terpopuler